Wolverine Stack (BPC-157/TB-500 combination)
BPC-157 + TB-500 | Tissue Repair & Recovery Protocol
Community Research
Join others researching Wolverine Stack — share findings, ask questions, and learn from real experiences
Combines BPC-157 and TB-500 for synergistic tissue repair and recovery. 87.5% improvement in knee pain patients per Lee & Padgett 2021 study.
BPC-157 increases actin production and modulates nitric oxide for vascular effects; TB-500 sequesters actin for cell migration; synergistic enhancement of fibroblast and immune cell movement to injury sites.
Molecular Data
N/A Complex or non-standard sequence format
Research Indications
Both peptides show evidence for accelerated repair; BPC-157 improved Achilles tendon healing in animal models.
BPC-157 demonstrates enhanced muscle regeneration; TB-500 promotes cell migration essential for repair.
Lee & Padgett study showed 87.5% of knee pain patients improved with BPC-157/TB4 combination.
TB-500 Phase 2 trials showed approximately one month faster healing in ulcer patients.
Both peptides modulate inflammatory pathways through different mechanisms.
Dosing Protocols
Subcutaneous injection recommended; most studied and effective route.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| General Recovery Protocol | BPC-157: 250mcg 2x/day + TB-500: 2mg 2x/week | BPC-157 daily, TB-500 twice weekly | SubQ |
| Intensive Injury Recovery | BPC-157: 500mcg 2x/day + TB-500: 2.5mg 2x/week | BPC-157 daily, TB-500 twice weekly | SubQ near injury site |
| Maintenance/Prevention Protocol | BPC-157: 250mcg 1x/day + TB-500: 2mg 1x/week | BPC-157 daily, TB-500 weekly | SubQ |
Reconstitution Instructions
- BPC-157 vial (5mg)
- TB-500 vial (2-5mg)
- Bacteriostatic water
- Insulin syringes (29-31 gauge)
- Alcohol swabs
- 1 Reconstitute each peptide separately
- 2 BPC-157: Add 2mL BAC water to 5mg vial = 250mcg per 0.1mL
- 3 TB-500: Add 2mL BAC water to 5mg vial = 250mcg per 0.1mL
- 4 Inject slowly along vial wall; swirl gently—never shake
- 5 Store reconstituted peptides refrigerated at 2-8°C
- 6 Do NOT mix peptides in same syringe unless pre-made blend
- 7 Use separate injection sites if administering same day
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
- Not extensively documented in human studies
- Generally well-tolerated in available research
Stop Signs - Discontinue if:
- Any unusual lumps, growths, or rapid tissue changes
- Severe injection site reactions or infections
- Signs of allergic reaction (rash, swelling, difficulty breathing)
- Unexpected bleeding or bruising
- Persistent headaches or vision changes
- Any symptoms suggesting abnormal growth
Contraindications
- ANY history of cancer or suspicious growths
- Active malignancy or concurrent chemotherapy
- Pregnancy or breastfeeding
Quality Checklist
Good Signs
- White or off-white lyophilized powder cake indicating proper freeze-drying
- Crystal clear solution after reconstitution with bacteriostatic water
- Certificate of Analysis with HPLC purity testing (>98%) and mass spectrometry verification
Warning Signs
- Minor clumping acceptable if dissolves completely with gentle swirling
Bad Signs
- Collapsed, yellowed, or powder stuck to vial sides—may indicate degradation from heat
- Persistent cloudiness or visible particles after reconstitution—indicates contamination or degradation
References
- Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainLee E, Padgett BAlternative Therapies in Health and Medicine (2021)
16 patients, intra-articular injection: Overall 87.5% (14/16) experienced knee pain relief. BPC-157 alone: 91.6% improvement (11/12). BPC-157 + TB4 combination: 75% improvement (3/4).
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic ReviewVasireddi A, et al.HSS Journal (2025)
36 articles reviewed (544 screened, 1993-2024). Preclinical models showed improvements in muscle tears, tendon ruptures, ligament tears, and fracture healing. Mechanism involves enhanced GH receptor expression and angiogenesis.
- The Regenerative Peptide Thymosin Beta-4 Accelerates the Rate of Dermal Healing in Preclinical Animal Models and in PatientsTreadwell T, Kleinman HK, Crockford D, Hardy MA, Goldstein ALAnnals of the New York Academy of Sciences (2012)
Two Phase 2 clinical trials of stasis and pressure ulcers showed thymosin beta-4 accelerated wound healing by approximately one month in responsive patients.
- Thymosin Beta-4: A Multi-Functional Regenerative Peptide. Basic Properties and Clinical ApplicationsGoldstein AL, Hannappel E, Sosne G, Kleinman HKExpert Opinion on Biological Therapy (2012)
Comprehensive review: thymosin beta-4 promotes cell migration, mobilizes stem/progenitor cells, forms new blood vessels, regenerates tissue, and reduces inflammation, apoptosis, and scar formation.
- Gastric Pentadecapeptide BPC 157 Accelerates Healing of Transected Rat Achilles Tendon and In Vitro Stimulates Tendocytes GrowthStaresinic M, Petrovic I, Novinscak T, et al.Journal of Orthopaedic Research (2003)
Rats, 10 mcg/kg i.p. daily, 14 days: BPC-157 fully improved biomechanical properties (load of failure, Young's modulus), functional recovery (Achilles functional index), and histological healing of transected Achilles tendons.
- Thymosin Beta-4 Accelerates Wound HealingMalinda KM, Sidhu GS, Mani H, et al.Journal of Investigative Dermatology (1999)
Rats, full thickness wounds: topical or intraperitoneal thymosin beta-4 increased re-epithelialization by 42% at 4 days and up to 61% at 7 days, with increased collagen deposition and angiogenesis.
Related Peptides
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.